Panagora Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,020
Closed -$93K 1625
2022
Q1
$93K Sell
13,020
-94
-0.7% -$778 ﹤0.01% 1502
2021
Q4
$238K Buy
+13,114
New +$283K ﹤0.01% 1440
2021
Q3
Sell
-2,448
Closed -$110K 2516
2021
Q2
$110K Buy
2,448
+291
+13% +$13.5K ﹤0.01% 1871
2021
Q1
$108K Buy
+2,157
New +$147K ﹤0.01% 1982

Other funds holding CELL

Panagora Asset Management's CELL Position: Q2 2022 in Review

Panagora Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 13,020 shares — an estimated $93K sold.

Panagora Asset Management first reported a position in CELL in Q1 2021 and held it in 4 quarters. The position peaked at $238K in Q4 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

  • Panagora Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Panagora Asset Management sold 13,020 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $93K.
  • Panagora Asset Management first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Panagora Asset Management's PhenomeX Inc. Common Stock position peaked at $238K in Q4 2021.
  • 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.